- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine whether abiraterone acetate in combination with low-dose prednisone and androgen deprivation therapy (ADT) is superior to ADT alone in improving rPFS and OS in subjects with mHNPC with high-risk prognostic factors.
Inclusion criteria
- Metastatic Hormone-Naive Prostate Cancer (mHNPC)